Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004734 · ClinicalTrials.gov registry record · Phase 3
Vitamin Therapy for Prevention of Stroke
A Phase 3 study of Stroke and Myocardial Infarction, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00004734: Completed Phase 3 study of Stroke and Myocardial Infarction, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00004734 is a Phase 3 study of Stroke and Myocardial Infarction that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004734, a Phase 3 study of Stroke and Myocardial Infarction, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
A stroke occurs when part of the brain is damaged from lack of normal blood supply. This may result in difficulty with feeling, speech, muscle strength or coordination, movement, thinking, or other brain functions. Having a stroke increases the risk of another stroke occurring in the future. Higher blood levels of a natural chemical known as homocysteine may contribute to hardening of the arteries in the brain or heart and increase the risk of stroke or heart attack. Folic acid, vitamin B6 (pyridoxine), and vitamin B12 (cyanocobalamin) may lower blood levels of homocysteine and reduce the risk of having another stroke or a heart attack.
Conditions Studied
Interventions
- DRUG pyridoxine
- DRUG cyanocobalamin
- DRUG folic acid multivitamin
Study Locations (1)
North Carolina
- Wake Forest University School of Medicine - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-09 |
| Est. Completion | 2004-02 |
| Phase | Phase 3 |
What the finished NCT00004734 record still lists
NCT00004734 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which pyridoxine is the first listed.
NCT00004734 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00004734 about?
NCT00004734 is a clinical study titled "Vitamin Therapy for Prevention of Stroke". A stroke occurs when part of the brain is damaged from lack of normal blood supply. This may result in difficulty with feeling, speech, muscle strength or coordination, movement, thinking, or other brain functions. Having a stroke increases the risk of another stroke occurring in the future. Higher ...
What is the current status of trial NCT00004734?
This trial is currently completed. It is a Phase 3 study. The study started on 1996-09. Estimated completion is 2004-02.
What conditions does trial NCT00004734 study?
This clinical trial studies the following conditions: Stroke, Myocardial Infarction, Cerebral Infarction.
What interventions are being tested in trial NCT00004734?
The interventions under investigation include: pyridoxine (DRUG), cyanocobalamin (DRUG), folic acid multivitamin (DRUG).
Who is sponsoring clinical trial NCT00004734?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004734 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RECRUITING · Phase 3
-
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
ACTIVE NOT RECRUITING · Phase 3
-
Locomotor Experience Applied Post Stroke Trial
COMPLETED · Phase 3
-
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
COMPLETED · Phase 3
-
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
COMPLETED · Phase 3
-
Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia